Simplify Health Care ETF (PINK) is an actively managed exchange-traded fund that seeks long-term capital appreciation by investing primarily in U.S. healthcare equities, including innovative companies across biotech, medtech, gene therapy, pharmaceuticals, and other fast-growing healthcare-related sectors; it employs fundamental bottom-up analysis and active stock selection, with top holdings such as Eli Lilly & Co., Amgen Inc., Gilead Sciences Inc., Mineralys Therapeutics Inc., and AbbVie Inc.; the fund also provides exposure through other healthcare ETFs and commits 100% of its net profits, in the form of the annual management fee, to the Susan G. Komen breast cancer foundation, having donated $350,000 as of September 1, 2025. PINK was launched on October 7, 2021, and is issued and managed by Simplify Asset Management Inc., an SEC-registered investment adviser founded in 2020 with headquarters in Las Vegas, Nevada, and additional operations in New York. The ETF trades on U.S. exchanges, targets investors seeking healthcare sector growth with philanthropic impact, and maintains assets under management of approximately $217 million with a net expense ratio of 0.50%. In recent developments, Simplify Asset Management, the issuer of PINK, signed a letter of intent in September 2025 with Streamex Corp. to explore a strategic partnership integrating tokenized yield-bearing gold into ETF structures, aiming to co-develop innovative exchange-traded products combining blockchain technology with regulated commodities exposure, subject to definitive agreements and regulatory approvals; additionally, Simplify launched the CTAP ETF in December 2025, expanding its lineup of equity-plus strategies with managed futures exposure.